Accurate diagnosis of multiple sclerosis requires careful attention to its differential diagnosis—
many disorders can mimic the clinical manifestations and paraclinical findings of this …

Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) is a spectrum of diseases,
including optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, and …

Background and Objectives Myelin oligodendrocyte glycoprotein (MOG) antibody–
associated disease (MOGAD) is a recently identified autoimmune demyelinating disorder of …

Inflammatory myelopathies can manifest with a combination of motor, sensory and
autonomic dysfunction of variable severity. Depending on the underlying etiology, the …

New diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease
(MOGAD) have recently been proposed, distinguishing this syndrome from other …

Although B cells are implicated in multiple sclerosis (MS) pathophysiology, a predictive or
diagnostic autoantibody remains elusive. In this study, the Department of Defense Serum …

Spinal cord involvement can be observed in the course of immune-mediated disorders.
Although multiple sclerosis (MS) represents the leading cause of inflammatory myelopathy …

Objective The aim of this study was to assess the diagnostic utility of cerebrospinal fluid
(CSF) myelin oligodendrocyte glycoprotein antibodies (MOG‐IgG) testing. Methods We …

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
immune-mediated inflammatory demyelinating disease of the central nervous system. This …

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an
inflammatory demyelinating disease that is distinct from multiple sclerosis. Initial …